Brain Ageing Biochemistry and Therapeutics
Sebastian A. Brunemeier is a biotech founder and VC investor, focusing on the biology of ageing. Sebastian was previously a Principal at Apollo Health Ventures, the first and largest aging-focused venture capital fund in the world, as well as Co-Founder and Chief Investment Officer at Cambrian Biopharma, a biotech VC holding company focused on the biology of aging. Sebastian was CEO of Cyclone Therapeutics, a Scripps Research Institute spinout focused on proteostasis. He also was the founding EIR and COO of Samsara Therapeutics, focused on autophagy-enhancing small molecule drug discovery in Oxford, UK, which was recognized as ‘best startup’ at the Financial Times Pharma Conference. Prior to Apollo, he was a Fulbright Fellow in the biology of aging at the Gulbenkian Institute, awarded the Skaggs-Oxford fellowship at the Scripps Research Institute, and a SENS Foundation Scholar at the Buck Institute for Research on Aging. His education includes DPhil (PhD) training on the biochemistry of aging at the University of Oxford as a Clarendon Scholar, an MSc in Life Science Business Management and an MSc in Molecular Neuroscience from the University of Amsterdam as an Amsterdam Excellence Scholar. He served as a trustee of the British Society for Research on Aging and is an advisor to McKinsey & Company.
Surveying the underlying molecular and cellular neuroscience of brain ageing, in addition to a critique of currently fashionable themes in CNS drug discovery (with a focus on Alzheimer’s dementia).
Date:
22 February 2021, 18:30 (Monday, 6th week, Hilary 2021)
Venue:
Venue to be announced
Speaker:
Sebastian A. Brunemeier (Founder, Samsara Therapeutics; Principal, Apollo Ventures)
Organiser:
Oxford Society of Ageing and Longevity (University of Oxford)
Host:
Oxford Society of Ageing and Longevity (University of Oxford)
Booking required?:
Required
Booking url:
https://l.facebook.com/l.php?u=https%3A%2F%2Fwww.eventbrite.co.uk%2Fe%2Fbrain-ageing-biochemistry-and-therapeutics-tickets-142076331131%3Ffbclid%3DIwAR36DkgiQbdKSNDnYuOdmN5hnA5pd942JbZWzoexr8uaKCt6BbD
Cost:
FREE
Audience:
Public
Editor:
Emily Monts